Simultaneous suppression of the MAP kinase and NF-κB pathways provides a robust therapeutic potential for thyroid cancer

The MAP kinase and NF-κB signaling pathways play an important role in thyroid cancer tumorigenesis. We aimed to examine the therapeutic potential of dually targeting the two pathways using AZD6244 and Bortezomib in combination. We evaluated their effects on cell proliferation, cell-cycle progression...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Lett
Main Authors: Tsumagari, Koji, Abd Elmageed, Zakaria Y., Sholl, Andrew B., Friedlander, Paul, Abdraboh, Mohamed, Xing, Mingzhao, Boulares, A. Hamid, Kandil, Emad
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4555189/
https://ncbi.nlm.nih.gov/pubmed/26208433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2015.07.011
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares